Patents by Inventor Nicole PRADA

Nicole PRADA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ASSAY TO DETECT AND QUANTITATE SPECIFIC ANTIBODIES FOR VARIOUS REDOX FORMS OF HMGB1
    Publication number: 20220317131
    Abstract: The invention relates to the quantitation of specific antibodies for at least one redox form of High mobility group box 1 (HMGB1) contained in a biological sample, in particular human serum and/or Cerebrospinal Fluid (CSF). The invention also relates to an in vitro method for assessing the state of progression of a disease or a disorder in which HMGB1 is involved, to an in vitro method for the identification of predisposition, prognostic or diagnostic biomarkers of a disease or a disorder in which HMGB1 is involved. The invention also relates to a kit to quantitate said specific antibodies for at least one redox form of HMGB1, in particular human HMGB1.
    Type: Application
    Filed: June 24, 2022
    Publication date: October 6, 2022
    Applicant: INSTITUT PASTEUR
    Inventors: Marie-Lise GOUGEON, Nicole PRADA, Hela SAIDI
  • Assay to detect and quantitate specific an antibodies for various redox forms of HMGB1
    Patent number: 11460473
    Abstract: Quantitation of specific antibodies for at least one redox form of High mobility group box 1 (HMGB1) contained in a biological sample. An in vitro method for assessing the state of progression of a disease or a disorder in which HMGB1 is involved. An in vitro method for the identification of predisposition, prognostic or diagnostic biomarkers of a disease or a disorder in which HMGB1 is involved. A kit to quantitate said specific antibodies for at least one redox form of HMGB1.
    Type: Grant
    Filed: November 3, 2016
    Date of Patent: October 4, 2022
    Assignee: INSTITUT PASTEUR
    Inventors: Marie-Lise Gougeon, Nicole Prada, Hela Saidi
  • AN ASSAY TO DETECT AND QUANTITATE SPECIFIC ANTIBODIES FOR VARIOUS REDOX FORMS OF HMGB1
    Publication number: 20180313848
    Abstract: The invention relates to the quantitation of specific antibodies for at least one redox form of High mobility group box 1 (HMGB1) contained in a biological sample, in particular human serum and/or Cerebrospinal Fluid (CSF). The invention also relates to an in vitro method for assessing the state of progression of a disease or a disorder in which HMGB1 is involved, to an in vitro method for the identification of predisposition, prognostic or diagnostic biomarkers of a disease or a disorder in which HMGB1 is involved. The invention also relates to a kit to quantitate said specific antibodies for at least one redox form of HMGB1, in particular human HMGB1.
    Type: Application
    Filed: November 3, 2016
    Publication date: November 1, 2018
    Inventors: Marie-Lise GOUGEON, Nicole PRADA, Hela SAIDI